This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: The standard drug treatment for Parkinson's disease is the daily administration of a. ... (Read 39 times)

jessicacav

  • Hero Member
  • *****
  • Posts: 558
on: Jun 22, 2018
The standard drug treatment for Parkinson's disease is the daily administration of
 
  a. d-amphetamine.
  b. L-DOPA.
  c. atropine.
  d. haloperidol.
  e. apomorphine.

Question 2

A genetic disorder caused by a mutation that produces a protein with toxic consequences would be classified as
 
  a. a toxic gain of function.
  b. recessive.
  c. a toxic loss of function.
  d. congenital.
  e. degenerative.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

perkiness

  • Sr. Member
  • ****
  • Posts: 348
Reply #1 on: Jun 22, 2018
Answer to Question 1

Answer: b. L-DOPA.

Answer to Question 2

Answer: a. a toxic gain of function.


jessicacav

  • Member
  • Posts: 558
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)

tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

« previous next »
 

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

(A) A 62-year-old patient with myxedema exhibiting marked edema of the face and a somnolent look. Th (A) A 62-year-old patient with myxedema exhibiting marked edema of the face and a somnolent look. Th
) IV bolus administration. (b) the drug is administered through the port using a needleless syring ) IV bolus administration. (b) the drug is administered through the port using a needleless syring
Drug Classification and Description of Use Drug Classification and Description of Use
Types of cellular receptors: (a) Drug binds to the receptor opening channel. (b) Drug binds to the ... Types of cellular receptors: (a) Drug binds to the receptor opening channel. (b) Drug binds to the ...
Four hazardous materials incidents. Clockwise from top left: a clandestine drug lab dump site, ... Four hazardous materials incidents. Clockwise from top left: a clandestine drug lab dump site, ...
A buffer solution is prepared using 0.5 moles of a weakly basic drug and an unknown quantity of ... A buffer solution is prepared using 0.5 moles of a weakly basic drug and an unknown quantity of ...
Video: Skin Cancer

For a complete list of videos, visit our video library